Latest Stock Split Details
Key information about Steminent Biotherapeutics Inc.'s most recent stock split
Split Date: 2026-04-29
Split Ratio: 203:200
Price Before Split: $80.69
Price After Split: $79.50
Developer API
Get 7729.TWO split history as JSON
Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.
GETapi.roic.ai/v2/stock-splits/7729.TWO
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 1.01 times more shares (a 203:200 ratio)
- The price per share is reduced proportionally
Historical Stock Splits
A comprehensive history of Steminent Biotherapeutics Inc.'s stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2026-04-29 | 203:200 | No | $80.69 | $79.50 |
| 2025-08-28 | 1071:1000 | No | $52.61 | $49.13 |
About Steminent Biotherapeutics Inc.
Company overview and industry information
Steminent Biotherapeutics Inc. (7729.TWO) operates in the Biotechnology industry. The recent 203-for-200 stock split reflects the company's growth and strategy to make shares more accessible to a broader range of investors.
Biotechnology
Go to Steminent Biotherapeutics Inc. Summary